NEW YORK, March 5, 2015 /PRNewswire/ -- In vitro diagnostic (IVD) companies have been very active with acquisitions to boost market share, and Kalorama Information sees that trend continuing. The finding was made in a recent report from the healthcare market research publisher. IVD products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions. Kalorama's Mergers and Acquisitions in the IVD Market shows how dynamic the IVD industry currently is, recording and examining some 130 significant acquisitions that have taken place from 2012 to early 2015.
Mergers and Acquisitions in the IVD Market can be found at KI: http://www.kaloramainformation.com/Mergers-Acquisitions-IVD-8769747/.
Generally, an IVD company acquires another to do one or more of the following:
- acquire a new IVD technology
- enter a new segment of the IVD market
- counter a competitor
- open a distribution channel
Kalorama notes that in the IVD industry, the goal is to build better tests and stronger companies. The future of the industry lies in the development of more sensitive, faster, user-friendly, IT-capable devices for a host of new protein and molecular markers. No company, big or small, owns all of the technology needed to develop these new tests and systems. They have to get the pieces they do not have from acquisitions and partnerships.
Recent acquisitions illustrate this, such as Roche's accessing a new technology with their acquisition of Signature Diagnostics. Roche will leverage Signature's expertise in both biobanks and next generation sequencing assays to develop novel diagnostics for cancer patients. Thermo Fisher's acquisition of Life Technologies opens up a new segment of the market for Thermo, making Thermo a major participant in the next-generation sequencing space, a segment in which the company had not previously been a strong player.
Overall, uncertainty in reimbursement and healthcare reform in Europe and the U.S. have changed the acquisition landscape. Some deals allow larger companies to acquire new technologies and enter new segments, but still others are distinct moves meant to set up toeholds in emerging countries. This aspect of IVD mergers and acquisitions is discussed in Mergers and Acquisitions in the IVD Market as well.
Strengthened by these many acquisitions, the goal of the IVD industry is to move beyond interoperability challenges and refocus energy on advancing healthcare. Next steps include the creation of the coming generation of IVD products, which will integrate the clinical lab into the mainstream of healthcare information flow. Mergers and Acquisitions in the IVD Market can be found at KI: http://www.kaloramainformation.com/Mergers-Acquisitions-IVD-8769747/.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
SOURCE Kalorama Information
Share this article